-+ 0.00%
-+ 0.00%
-+ 0.00%

Tianjin Pharmaceutical (600488.SH): Diphenhydramine hydrochloride chemical raw material approved for marketing

Zhitongcaijing·11/16/2026 07:41:04
Listen to the news

Zhitong Finance App News, Jinyao Pharmaceutical (600488.SH) issued an announcement. Recently, the company received the “Notice of Approval of Application for the Marketing of Chemical Ingredients” for diphenhydramine hydrochloride approved and issued by the State Drug Administration. As a first-generation antihistamine, diphenhydramine hydrochloride inhibits the central nervous system, thereby preventing histamine from binding to H1 receptors and reducing allergic reactions. It is mainly used to treat allergic dermatitis, urticaria, allergic rhinitis, etc. It has good anti-allergic and anti-itch effects, accurate curative effect, and remarkable improvement of symptoms. Currently, the dosage forms on the market mainly include tablets, injections, etc.